Skip to content
2000
Volume 2, Issue 4
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Amyloid beta peptide (Aβ) is implicated in the pathogenesis of Alzheimer's disease (AD), particularly as oligomers or polymers that are correlated with Ab cellular toxicity. Inhibition of the formation of toxic forms of Aβ has therefore emerged as one approach to the treatment of AD. This article reviews efforts to adapt the structure of Aβto the design and testing of peptide-based inhibitors of Aβ polymerization of interest as potential AD therapeutics.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026024607508
2002-04-01
2025-06-07
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026024607508
Loading

  • Article Type:
    Review Article
Keyword(s): Amyloid beta peptide; Beta Amyloid Aggregation; Peptide Inhibitors
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test